Trusted News Discovery Since 2008
{{/content}}
Covid vaccine: How to register, where to go, what you need | All key details
Video Credit: HT Digital Content
Published on March 1, 2021 - Duration: 04:31s
Covid vaccine: How to register, where to go, what you need | All key details
Phase 2 of India's Covid-19 vaccination drive was launched in high-profile manner on March 1 with Prime Minister Narendra Modi becoming one of the first beneficiaries.
The second phase of the programme involves inoculation of those aged 60 and above, and those aged 45+ with comorbidities.
The process for registration involves entry of mobile number and identity card details on the government's dedicated Co-win platform.
India currently has 2 vaccines in use - Bharat Biotech's Covaxin, and Oxford-AstraZeneca's Covishield, being manufactured by the Serum Institute of India.
Watch the full video for more.
You are here
đĄ newsR Knowledge: Other News Mentions
COVID-19
Disease caused by severe acute respiratory syndrome coronavirus 2
Credit: IndiaTimes - Published 10 minutes ago
The Delhi government has ordered lodging of FIRs against four airlines â IndiGo, Vistara, SpiceJet, AirAsia India â for allegedly not checking the RT-PCR..
Credit: IndiaTimes - Published 10 minutes ago
Singh said he is forwarding his suggestions for consideration in a spirit of constructive cooperation in which he has always believed and acted upon.
Credit: DNA - Published 1 hour ago
Credit: IndiaTimes - Published 2 hours ago
Narendra Modi
14th and current Prime Minister of India
Credit: IndiaTimes - Published 2 hours ago
Credit: IndiaTimes - Published 4 hours ago
At Katwa in East Burdwan, Mamata said the CID had been asked to track down the person/s responsible for intercepting her phone conversations, adding that even PM..
Credit: IndiaTimes - Published 15 hours ago
Credit: IndiaTimes - Published 19 hours ago
OxfordâAstraZeneca COVID-19 vaccine
Vaccine against COVID-19
Both Covaxin and Covishield â the two vaccines against Covid in use in India â are effective against the UK variant, which is one the two prevailing..
Credit: IndiaTimes - Published 6 days ago
The Vietnamese envoy joins other envoys in getting vaccinated. Earlier this month, Australian envoy got vaccinated using Covishield vaccine.
Credit: DNA - Published 6 days ago
This is the third COVID-19 vaccine approved by the Subject Expert Committee (SEC) after Covishield and Covaxin.
Credit: DNA - Published 6 days ago
The safety committee of the European Medicines Agency (EMA) has asked those receiving the AstraZeneca vaccine (called Covishield in India) and medical..
Credit: IndiaTimes - Published 1 week ago
AstraZeneca
British-Swedish pharmaceutical company
BBV152
Vaccine against COVID-19
The PMâs directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and..
Credit: IndiaTimes - Published 16 hours ago
Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
Credit: DNA - Published 2 days ago
The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
Credit: IndiaTimes - Published 2 days ago
Bharat Biotech
Indian biotechnology company and vaccine manufacturer
Indications are that Indiaâs vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and..
Credit: IndiaTimes - Published 1 week ago
Serum Institute of India
Indian biotechnological company, vaccine manufacturer
Related videos from verified sources
Congress alleges âpreferential treatmentâ to some states by Centre | Covid 04:08
Video credit: HT Digital Content - Published 20 hours ago
Watch: Top doctor gives 2 reasons behind Covid surge in India & the way forward 03:19
Video credit: HT Digital Content - Published 23 hours ago
Pfizer CEO Says 3rd Dose of COVID-19 Vaccine Is âLikelyâ Needed 01:05
Video credit: Wibbitz Top Stories - Published 2 days ago